BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 12, 2015
View Archived Issues
Recent FDA orphan drug designations
Read More
AstraZeneca profiles pipeline highlights of third quarter 2015
Read More
MedImmune initiates first-in-human study of MEDI-4166 for type 2 diabetes
Read More
Discovery of small-molecule bacterial riboswitch inhibitors
Read More
FUJIFILM to begin phase I trial of FF-10101 in the U.S.
Read More
Boehringer Ingelheim establishes new collaborations to advance research in IBD
Read More
Shionogi and GSK to independently develop collaboration on cephalosporin antibiotics
Read More
FDA issues complete response letter for Cotempla XR-ODT NDA
Read More
Astellas Pharma discloses preclinical and first-in-human phase I results of ASP-5878
Read More
4D Pharma obtains approval to conduct phase I trial of Thetanix
Read More
Afferent Pharmaceuticals begins phase II trial of AF-219 for cough in IPF
Read More
XF-73 receives FDA QIDP designation
Read More
Partial hold removed from encenicline trial for cognitive impairment in schizophrenia
Read More
LEO Pharma to acquire global dermatology portfolio from Astellas Pharma
Read More
Novel inhibitors block LIM kinase activity in cancer cell lines
Read More
New phase II trial investigates combination of CMB-305 and atezolizumab for soft tissue sarcoma
Read More
Boehringer Ingelheim announces multibillion-euro R&D investment program
Read More
MD Anderson explores new lirilumab combination regimen for MDS
Read More
Mitsubishi Tanabe Pharma patents CYP11B2 inhibitors
Read More
Incyte describes Brd4 inhibitors
Read More
Taisho Pharmaceutical divulges EGLN1 inhibitors
Read More
Stanford University reports development of anti-CD99 MAbs
Read More
GamaMabs Pharma presents anti-HER4 human MAbs
Read More
World Pneumonia Day: reducing delivery restraints and fighting antibiotic resistance
Read More
